Collier William H. 4
4 · Arbutus Biopharma Corp · Filed Jun 1, 2020
Insider Transaction Report
Form 4
Collier William H.
DirectorPresident and CEO
Transactions
- Award
Stock Options
2020-05-28+262,313→ 262,313 totalExercise: $3.35Exp: 2030-02-17→ Common Stock (262,313 underlying)
Footnotes (3)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on February 14, 2020, the trading day immediately preceding the date the option grant was approved by the Executive Compensation and Human Resources Committee of the Board of Directors (the "Committee") of Arbutus Biopharma Corporation, subject to shareholder approval of an amendment to the Registrant's 2016 Omnibus Share and Incentive Plan (the "Plan Amendment").
- [F2]The option grant was approved by the Committee on February 17, 2020, subject to shareholder approval of the Plan Amendment. The Registrant's shareholders approved the Plan Amendment on May 28, 2020.
- [F3]The stock option will vest and become exercisable as to 3/48ths of the common shares on the grant date and an additional 1/48th of the total original common shares on the 17th day of each of the next 45 months.